Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
HIV Medicine|August 18, 2009
Long-term (96-week) follow-up of antiretroviral-naïve HIV-infected patients treated with first-line lopinavir/ritonavir monotherapy in the MONARK trialJade Ghosn, P Flandre, I Cohen-Codar, et al.
The New England Journal of Medicine|October 29, 1998
A randomized trial of three maintenance regimens given after three months of induction therapy with zidovudine, lamivudine, and indinavir in previously untreated HIV-1-infected patients. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study TeamG Pialoux, F Raffi, F Brun-Vezinet, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 11, 2001
Salivary cytomegalovirus (CMV) shedding, glycoprotein B genotype distribution, and CMV disease in human immunodeficiency virus-seropositive patientsN Fidouh-Houhou, X Duval, F Bissuel, et al.
HIV Medicine|March 16, 2012
Body fat distribution in HIV-infected patients treated for 96 weeks with darunavir/ritonavir monotherapy versus darunavir/ritonavir plus nucleoside reverse transcriptase inhibitors: the MONOI-ANRS136 substudyM A Valantin, S Kolta, P Flandre, et al.
The Journal of Antimicrobial Chemotherapy|May 28, 2016
Usefulness of an HIV DNA resistance genotypic test in patients who are candidates for a switch to the rilpivirine/emtricitabine/tenofovir disoproxil fumarate combinationS Lambert-Niclot, C Allavena, M Grude, et al.
Journal of Medical Virology|March 25, 2008
National survey of the prevalence and conditions of selection of HIV-1 reverse transcriptase K70E mutationC Delaugerre, P Flandre, A G Marcelin, et al.
JAMA|January 14, 2000
Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study Team)D Descamps, P Flandre, V Calvez, et al.
The Journal of Antimicrobial Chemotherapy|December 5, 2013
Rilpivirine, emtricitabine and tenofovir resistance in HIV-1-infected rilpivirine-naive patients failing antiretroviral therapyS Lambert-Niclot, C Charpentier, A Storto, et al.
HIV Clinical Trials|February 3, 2006
Early virologic failure and rescue therapy of tenofovir, abacavir, and lamivudine for initial treatment of HIV-1 infection: TONUS studyR Landman, D Descamps, G Peytavin, et al.
The Journal of Antimicrobial Chemotherapy|January 31, 2013
Prevalence of pre-existing resistance-associated mutations to rilpivirine, emtricitabine and tenofovir in antiretroviral-naive patients infected with B and non-B subtype HIV-1 virusesS Lambert-Niclot, C Charpentier, A Storto, et al.
Pageof 4